$0.315
0.010 (3.28%)
|
High $0.32 |
Low $0.30 |
Trades 243 |
Turnover $627,825 |
Volume 2,012,212 |
| 30 June 2023 at 4:10pm | ||||
IMMUTEP LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $36,843,036 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (9-Nov) 20,215,263 (1.37%) (219th) |
|
52w High $0.470 |
52w Low $0.020 |
P/E 7.20 |
EPS -0.05 |
[ARTICLE] Global immunity is prescription for return to normality
A news article has been posted about Immutep on the AFR. The article was published around , on 16 December 2020 at 12:14am.
Vaccination will be no magic bullet to restore Australia to full normality. Because unless everyone is immune, no one is immune.
Read ArticleIMM was $0.41 at the close of trade on 15 December 2020
Find all articles about Immutep, including others on the AFR, on the media page.
If you were already registered, log in here.
If you were already registered, log in here.